BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 322658)

  • 1. Alloxan cytotoxicity in vitro. Microscope photometric analyses of Trypan Blue uptake by pancreatic islet cells in suspension.
    Grankvist K; Lernmark A; Täljedal IB
    Biochem J; 1977 Jan; 162(1):19-24. PubMed ID: 322658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells.
    Grankvist K; Lernmark A; Täljedal IB
    J Endocrinol Invest; 1979; 2(2):139-45. PubMed ID: 226577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.
    Grankvist K; Marklund S; Sehlin J; Täljedal IB
    Biochem J; 1979 Jul; 182(1):17-25. PubMed ID: 40548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloxan cytotoxicity in vitro. Inhibition of rubidium ion pumping in pancreatic beta-cells.
    Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1977 Jan; 162(1):9-18. PubMed ID: 192215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate-induced free radical toxicity to isolated islet cells.
    Andersson M; Grankvist K
    Int J Biochem Cell Biol; 1995 May; 27(5):493-8. PubMed ID: 7641078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure and membrane permeability of cultured pancreatic beta-cells exposed to alloxan or 6-hydroxydopamine.
    Norlund R; Grankvist K; Norlund L; Täljedal IB
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(1):31-8. PubMed ID: 6433546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells.
    Borg LA; Eide SJ; Andersson A; Hellerström C
    Biochem J; 1979 Sep; 182(3):797-802. PubMed ID: 391224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorotetracycline as a fluorescent Ca2+ probe in pancreatic islet cells.
    Täljedal IB
    J Cell Biol; 1978 Mar; 76(3):652-74. PubMed ID: 344326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethyldithiocarbamate, but not disulfiram, inhibits alloxan-induced dye accumulation of isolated mouse islet beta-cells.
    Norlund L; Grankvist K; Hansson HA; Norlund R
    Med Biol; 1986; 64(1):37-41. PubMed ID: 3014237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alloxan on the islets of Langerhans: stimulation and inhibition of cyclic AMP production.
    Borg LA; Bone AJ
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):361-9. PubMed ID: 2993386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gossypol-induced free radical toxicity to isolated islet cells.
    Grankvist K
    Int J Biochem; 1989; 21(8):853-6. PubMed ID: 2684701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
    Boquist L
    Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alloxan on permeability and hexose transport in rat pancreatic islets.
    McDaniel ML; Anderson S; Fink J; Roth C; Lacy PE
    Endocrinology; 1975 Jul; 97(1):68-75. PubMed ID: 1095363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloxan reversibly impairs glucagon release and glucose oxidation by pancreatic A2-cells.
    Ostenson CG
    Biochem J; 1980 Apr; 188(1):201-6. PubMed ID: 6996677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1beta mediated suppression--possible involvement of the mitochondrial membrane potential.
    Kullin M; Li Z; Bondo Hansen J; Welsh N; Karlsson FA; Sandler S
    Diabetologia; 2003 Jan; 46(1):80-8. PubMed ID: 12637986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsphere distribution in the pancreas of anesthetized rats. Alloxan stimulates the blood flow to all islets whereas glucose only affects the blood perfusion of a subgroup of islets.
    Jansson L
    Int J Pancreatol; 1996 Aug; 20(1):69-74. PubMed ID: 8872526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell membrane alteration by diabetogenic drugs.
    Orci L; Amherdt M; Malaisse-Lagae F; Ravazzola M; Malaisse WJ; Perrelet A; Renold AE
    Lab Invest; 1976 May; 34(5):451-4. PubMed ID: 131879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.